SCHEMBL7125558

SCHEMBL7125558

N#Cc1ccc(NC(=O)c2nccs2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 4/20 0.53
LMNA P02545 3/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 1/20 0.49
KDR P35968 1/20 0.48
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
TAS1R2 Q8TE23 1/20 0.48
EGLN1 Q9GZT9 1/20 0.47
PTPN1 P18031 1/20 0.47
DUSP3 P51452 1/20 0.47
PTPN11 Q06124 1/20 0.47
PTPN22 Q9Y2R2 1/20 0.47
MLYCD O95822 1/20 0.46
CD38 P28907 1/20 0.45
MAPT P10636 2/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.45
NLRP3 Q96P20 1/20 0.45
CASP3 P42574 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6011016 0.81 GRM4 (0.58) GRM4ALDH1A1MAPTHTTCASP3
SCHEMBL7361894 0.80 GRM4 (0.53) GRM4ALDH1A1MAPTHTTCASP3
SCHEMBL6655345 0.80 KMT2A (0.61) GRM4LMNAKDRMAPTHTT
SCHEMBL470920 0.80 GRM4 (0.60) GRM4LMNAKDM4EALDH1A1MAPT
SCHEMBL1091625 0.80 GRM4 (0.56) GRM4LMNAALDH1A1MAPTCASP3
SCHEMBL168594 0.80 GRM4 (0.63) GRM4LMNAALDH1A1MAPTHTT
SCHEMBL12181073 0.80 ALDH1A1 (0.58) GRM4KDM4EALDH1A1HTTCASP3
SCHEMBL5164235 0.76 GRM4 (0.59) GRM4LMNAALDH1A1MAPTHTT
SCHEMBL8888399 0.74 ALDH1A1 (0.50) LMNAKDM4EALDH1A1TAS1R3TAS1R1
SCHEMBL1091450 0.73 NAMPT (0.52) GRM4CASP3SENP8SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311505-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS ) PHARMACIA & UPJOHN COMPANY (US) 2003-05-21 EP claimed
WO-2002015662-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed
WO-2002016355-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC) ACETYLCHOLINE RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed
WO-2002017358-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS) PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed